Real-World Predictors of Response to Immunotherapy in Metastatic Renal Cell Carcinoma: The Emerging Role of the Urologist in Immuno-Oncology.

Res Rep Urol · 2026 · PMC13159738 · PMID 42124559

Europe PMC DOI

hedged sentence

0.1130

closest p · 2.3× alpha

0.1130

boldest claim

The sentences

did not reach statistical significancep=0.113not close (p > 0.1)

Keywords renal cell carcinoma immunotherapy neutrophil-to-lymphocyte ratio cytoreductive nephrectomy survival analysis urologic oncology Other Clinical Predictors Female sex (9/32; 28%) and absence of synchronous metastases (9/32; 28%) were associated with trends toward longer OS, though these associations did not reach statistical significance in Cox models (both p=0.113).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.